Health

Results: 1957-1968 of 10168

VDYNE Receives FDA Approval to Initiate the TRIVITA1 IDE Pivotal Trial of Transcatheter Tricuspid Valve Replacement System

Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer

Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States

Alkermes Announces Initiation of Phase 3 Brilliance Studies Evaluating Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2

Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond

Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D

PR Newswire associated0

BD Launches AI-Enabled Medication Dispensing System to the European Market

IDEXX Cancer Dx Panel with lymphoma testing

IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma

ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions

PR Newswire associated0

Wegovy®▼(semaglutide injection) 2.4 mg recommended by NICE to reduce risk of major adverse cardiovascular events, including heart attacks and strokes, in adults with established cardiovascular disease and overweight or obesity (BMI ≥27 kg/m2)[1]

PR Newswire associated0

NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development

Europe faces a growing chronic wound crisis - time to act is now